MedTrace Logo

A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer Patients

NCT06518434 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-07-24

No results posted yet for this study

Summary

to study the anti-tumor effect of cannabis oil (THC10% / CBD5%) in untreatable HCC patients based on mRECIST and RECIST criteria

Conditions

Interventions

DRUG

Medical Cannabis

Medical cannabis oil three times daily

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • M W Nijkamp, MD PhD · University Medical Center Groningen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-15
Primary Completion
2027-04-15
Completion
2027-04-15

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06518434 on ClinicalTrials.gov